Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Ambrx, Astellas, Astrazeneca, Dong-A ST, Famygen Life Sciences, Fibrogen, Harbour Biomed, Kao, Kirin, Medicox, Moderna, Neurobo, Nona, Novocodex, Ocuphire, Oramed, Pfizer, Polifarma Ilac Sanayi VE Ticaret, Precisionlife, SK, Sosei, Telix.